Products Ciclesonide is administered with a metered-dose inhaler (Alvesco). It has been approved in many countries since 2006. In the United States, it has also been commercially available as a nasal spray for the treatment of allergic rhinitis since 2012 (Zetonna). Structure and properties Ciclesonide (C32H44O7, Mr = 540.7 g/mol) is a prodrug and is … Ciclesonide
Products Beclometasone is commercially available as a drug for inhalation and as a nasal spray (Qvar, Beclo Orion). It has been approved in many countries since 1998. This article refers to inhalation. See also under beclometasone nasal spray. Beclometasone is also combined with formoterol fix; see under Beclometasone and Formoterol (Foster). In 2020, a fixed … Beclometasone
Products Mometasone powder inhaler was approved in many countries since 2005 (Asmanex Twisthaler). Mometasone furoate is also used to treat skin disorders and to treat disorders of the nasal mucosa; see Mometasone (dermal) and Mometasone nasal spray. Structure and properties Mometasone (C22H28Cl2O4, Mr = 427.4 g/mol) is present in the drug as mometasone furoate, a … Mometasone Inhalation
Products Budesonide is commercially available as a monopreparation for inhalation as a powder inhaler and suspension (Pulmicort, generics). It is also combined fixed with formoterol (Symbicort Turbuhaler, Vannair Dosage Aerosol). This article refers to monotherapy. Budesonide has been approved in many countries since 1988. Structure and properties Budesonide (C25H34O6, Mr = 430.5 g/mol) is a … Budesonide (Inhalation)
